In CML, autophagy supports leukemic stem cell survival and TKI resistance by leveraging the same mTOR, PI3K/Akt, and AMPK pathways, which are also critical in the pathogenesis of neurodegenerative and metabolic disorders. The gene discussed is MTOR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.